Rizatriptan Orodispersable Tablets

Rizatriptan is a prescription medicine used to treat migraine attacks once they've started. It belongs to a family of medicines called triptans, the same class as sumatriptan, zolmitriptan, and eletriptan. In the UK it's available under the brand name Maxalt (made by Organon) and as generic rizatriptan, in two forms: standard 5 mg and 10 mg tablets, and Maxalt Melt 5 mg and 10 mg orodispersible wafers that dissolve on the tongue without water. Rizatriptan is used for acute treatment of migraine with or without aura. Unlike sumatriptan, it isn't available as a nasal spray or auto-injector, which means it's typically chosen by people whose migraines respond to oral medicines or who specifically benefit from the melt form.

This is the most useful comparison to address first, because patients arriving at rizatriptan have often tried sumatriptan and want to understand the difference. The two medicines work the same way (both are 5-HT1B/1D receptor agonists), but they differ in three practical respects. First, rizatriptan tends to work faster: peak blood levels are reached at around 1 hour with rizatriptan compared with about 2 hours for sumatriptan tablets, which can translate into faster pain relief in many people. Second, rizatriptan has higher oral bioavailability (around 45 per cent versus 14 per cent for sumatriptan), which means more of each tablet reaches the bloodstream and the doses needed are correspondingly lower. Third, rizatriptan is available as a melt wafer (Maxalt Melt) that dissolves on the tongue, which can be useful when nausea makes swallowing tablets unreliable. The trade-off is that rizatriptan doesn't come as a nasal spray or injection, so for the fastest possible onset (10 to 15 minutes), sumatriptan's injection form is still the option of choice. Many patients respond well to one triptan and less well to another, and it's reasonable to try two or three before concluding that triptans aren't right for you.

Migraine isn't a regular headache. During an attack, blood vessels in the head dilate, and a set of nerves around those vessels (the trigeminal nerves) release inflammatory chemicals that cause throbbing pain, nausea, sensitivity to light and sound, and the other classic migraine symptoms. Rizatriptan works on receptors called 5-HT1B and 5-HT1D, which sit on those dilated vessels and on the nerve endings around them. Activating 5-HT1B receptors causes the dilated vessels to constrict back to their normal size. Activating 5-HT1D receptors stops the trigeminal nerves releasing the inflammatory chemicals that drive the pain. The result is that the migraine attack is interrupted at its source rather than just having the pain dulled. This explains why triptans like rizatriptan can stop a migraine outright in many people, where simple painkillers can only take the edge off.

Maxalt Melt is an orodispersible wafer form of rizatriptan that dissolves on the tongue within seconds, without needing water. It contains the same active ingredient at the same strengths (5 mg or 10 mg) as the standard tablets. The melt form is particularly useful in three situations: when you're already nauseated and don't want to swallow water, when you don't have water to hand (during a meeting, on a plane, in the middle of the night), and when you have trouble swallowing tablets for any reason. One small misconception worth correcting: although the wafer dissolves on the tongue, the rizatriptan isn't absorbed through the cheek or under the tongue. It's absorbed in the stomach and intestine after the dissolved medicine is swallowed with saliva. That means the onset of action is roughly similar to standard tablets, around 30 minutes. The main advantage is convenience, not speed.

As early as possible after the headache phase begins. This is one of the most consistent findings in migraine research: triptans work much better when taken at the first sign of head pain than once a migraine is fully established. Many people with regular migraines learn to recognise the earliest signals: a slight visual disturbance, a dull ache behind one eye, a strange stiffness in the neck, or a sense that "something's coming". Acting at that point can often abort the attack entirely. Waiting until you're vomiting and lying down in a dark room reduces the chance of a good response significantly. If you have an aura before your headache, the usual advice is to wait until the headache itself starts before taking rizatriptan, because the aura phase doesn't respond to triptans and you don't want to use up a dose too early.

The standard starting dose is 10 mg at the onset of the headache. If the migraine comes back within 24 hours after an initial response, a second dose can be taken at least 2 hours after the first, up to a maximum of 20 mg in 24 hours. There's one important exception to the standard dose, and it's specific to rizatriptan: if you're taking propranolol (the most commonly prescribed migraine preventive), the dose must be reduced to 5 mg, with a maximum of 10 mg in 24 hours. Propranolol significantly raises rizatriptan blood levels, and the reduced dose accounts for this. Make sure your prescriber knows about all your other medicines for this reason. If you're using Maxalt Melt rather than tablets, the same dosing applies.

Rizatriptan typically starts to take effect within 30 minutes of swallowing the tablet or letting the wafer dissolve, with peak effect at around 1 to 1.5 hours, which is faster than most other oral triptans. About 70 per cent of people get meaningful pain relief within 2 hours of taking rizatriptan 10 mg at standard dose, and around 40 per cent are completely pain-free at 2 hours. Earlier dosing in the attack pushes those numbers up; waiting until the attack is fully established pushes them down. Rizatriptan is generally considered one of the slightly faster-acting oral triptans, which is one of the reasons it's a common choice for people who've found sumatriptan tablets too slow.

The general rule is to avoid taking a second dose for the same attack if the first dose had no effect at all. If it partially worked or worked and then wore off, a second dose can help, but if it did nothing at the first attempt, more of the same is unlikely to help. Options at that point include adding a painkiller such as ibuprofen or naproxen, an anti-sickness medicine like metoclopramide (which also helps the gut absorb other medicines better), or waiting the attack out in a dark, quiet room with hydration. For future attacks, it's worth a conversation with your prescriber about whether another triptan might work better. Triptans are not interchangeable; many people who don't respond to one will respond to another, and it's reasonable to try several before concluding the class doesn't work for you. Options to discuss include sumatriptan, zolmitriptan, eletriptan, almotriptan, naratriptan, and frovatriptan, each with slightly different speed and duration profiles.

Most people tolerate rizatriptan well, but it produces a fairly distinctive set of effects sometimes called "triptan sensations". These include tingling, a feeling of warmth or coolness, mild flushing, and a sense of pressure or tightness that can be felt in the chest, throat, neck, jaw, or limbs. The chest tightness in particular tends to alarm people the first time they experience it, because the natural assumption is that it's something cardiac. In healthy people without heart disease this sensation isn't dangerous and reflects the medicine's action on blood vessels and smooth muscle. It usually settles within 30 minutes to an hour. That said, real cardiac chest pain can also occur in someone with undiagnosed heart disease who takes a triptan, so the distinction matters. If the chest sensation is severe, prolonged, crushing, associated with breathlessness, or radiating down the arm, that needs urgent assessment rather than being assumed to be a "triptan sensation". Other common side effects include drowsiness, dizziness, fatigue, dry mouth, and nausea (although migraine itself causes nausea, so this can be hard to attribute).

A few interactions matter. Rizatriptan should not be taken with monoamine oxidase inhibitor antidepressants (MAOIs) or within two weeks of stopping one, because the combination can cause dangerous rises in blood pressure and serotonin syndrome. It shouldn't be taken with another triptan or with ergotamine-type migraine medicines on the same day, because the vasoconstriction effects can add up. As mentioned above, propranolol significantly raises rizatriptan blood levels and requires a dose reduction to 5 mg; this is a particularly distinctive interaction for rizatriptan, and worth flagging because propranolol is the most commonly prescribed migraine preventive in the UK. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), such as sertraline, citalopram, or venlafaxine, carry a small theoretical risk of serotonin syndrome when combined with triptans, though in practice this is rare. Lithium also carries a small theoretical risk. Always tell prescribers what else you're taking, including over-the-counter medicines and herbal remedies (St John's Wort is particularly relevant).

Yes, in most cases. Rizatriptan causes blood vessel constriction, including in the coronary arteries that supply the heart muscle. In someone with healthy arteries this is harmless and transient, but in someone whose coronary arteries are already narrowed by atherosclerosis, even a small additional constriction can reduce blood flow to the heart enough to cause angina or, in rare cases, a heart attack. Rizatriptan is therefore contraindicated in established ischaemic heart disease, previous heart attack, coronary artery vasospasm (Prinzmetal's angina), uncontrolled high blood pressure, previous stroke, and peripheral vascular disease. It's also used with caution in people who don't have known heart disease but who carry significant cardiovascular risk factors: men over 40, postmenopausal women, smokers, people with diabetes, raised cholesterol, or strong family history of premature heart disease. In those situations, a cardiovascular assessment before starting a triptan is often recommended.

The safety data for rizatriptan in pregnancy is more limited than for sumatriptan, partly because sumatriptan has been on the market for longer and has accumulated more registry data. What evidence exists doesn't show clear harm, but most clinicians prefer sumatriptan in pregnancy where a triptan is needed, because of the larger safety database. If you're pregnant and considering rizatriptan, the conversation is worth having with your GP rather than self-managing. In breastfeeding, rizatriptan passes into breast milk in small amounts, and the standard advice is to avoid breastfeeding for 24 hours after a dose. Some recent guidance is less strict, but the 24-hour interval remains the conservative approach. Many women express and discard breast milk during that window to maintain supply.

This is one of the most important things to understand about triptans, because the danger isn't using them, it's using them too often. Medication overuse headache (MOH) is a surprisingly common problem in which the body's response to frequent triptan use becomes paradoxical: the medicines that were helping start producing rebound headaches, which then prompt more medicine use, in a cycle that can become entrenched. The current threshold is taking a triptan on more than 10 days a month, on average, for three or more months. Above that level, the risk of MOH rises significantly. If you find yourself reaching for rizatriptan 10 or more days a month, that's a strong signal that the conversation needs to shift from acute treatment to preventive treatment, which is a different category of medicine designed to reduce how often migraines happen in the first place. Treatment of medication overuse headache, somewhat counter-intuitively, involves stopping the overused medicine for a period to allow the headache pattern to reset, often with specialist guidance.

No, rizatriptan is an acute treatment: it interrupts a migraine once it's started. It doesn't change how often migraines happen, how severe they are, or any of the underlying drivers of the condition. Prevention is a separate category of treatment worth discussing with a clinician if your migraines are frequent (more than four a month is a common threshold), severely disabling, or not well controlled with acute treatment. Preventive options include beta-blockers (propranolol, which interacts with rizatriptan as noted above), topiramate, amitriptyline, candesartan, and the newer injected CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab). Botulinum toxin injections are also licensed for chronic migraine prevention. Beyond the preventive conversation, several features call for prompt medical review: a first-ever severe headache, particularly one that comes on suddenly or feels different from anything you've had before (which can be a warning of meningitis or subarachnoid haemorrhage and should be treated as an emergency); migraine lasting more than 72 hours without responding to treatment ("status migrainosus"); new neurological symptoms that don't fit your usual aura pattern; headaches that wake you from sleep, consistently get worse over weeks, or come with weight loss, fever, or other systemic symptoms. A clinical review is also worth having if your migraines are happening often, if rizatriptan isn't enough, if you're using it on more than 10 days a month, or if you've never had a formal migraine diagnosis. Modern migraine care has changed considerably in the last decade with the arrival of CGRP-targeting treatments, and many people who pushed through quietly for years do much better once they get into a proper plan.